Not Signed In -
Medroxyprogesterone |
Amen; Curretab; Cycrin; Provera |
Depo Provera Background B.C. type Hormonal First use ? Failure rates (per year) Perfect use 0.3% Typical use 0.3% Usage Duration effect 90 days (12weeks + 5 days) Reversibility 0-6months User reminders Maximum interval is just under 3months Clinic review 12 weeks Advantages Periods Usually no periods from 2nd injection Benefits Especially if poor pill compliance Disadvantages STD protection No Periods Especially in 1st injection may be frequent spo ...
Wikipedia - [full article]
Medroxyprogesterone Clinical Trials
- Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
ClinicalTrials.gov Identifier: NCT00003179 - Active, not recruiting
Endometrial Cancer
- Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
ClinicalTrials.gov Identifier: NCT00064025 - Recruiting
Endometrial Cancer
- Medroxyprogesterone in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00002920 - Active, not recruiting
Endometrial Cancer; stage I breast cancer; stage II breast cancer; intraductal breast carcinoma; lobular breast carcinoma in situ; ...
- Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
ClinicalTrials.gov Identifier: NCT00416429 - Active, not recruiting
Kidney Cancer
- Alzheimer's Disease: Therapeutic Potential of Estrogen
ClinicalTrials.gov Identifier: NCT00066157 - Active, not recruiting
Alzheimer Disease
- Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use with Certain Anti-HIV Drugs in HIV-Infected Women
ClinicalTrials.gov Identifier: NCT00016601 - Completed
HIV Infections
- Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
ClinicalTrials.gov Identifier: NCT00030914 - Completed
Hot Flashes
- Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
ClinicalTrials.gov Identifier: NCT00026286 - Active, not recruiting
stage I breast cancer; ductal breast carcinoma; menopausal symptoms; Hot Flashes; stage II breast cancer; breast cancer in situ
- Hormone Therapy in Preventing Endometrial Carcinogenesis (Cancer) in Women With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
ClinicalTrials.gov Identifier: NCT00033358 - Recruiting
Endometrial Cancer; hereditary non-polyposis colon cancer (hMSH2, hMLH1, hPMS1, hPMS2)
- Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss
ClinicalTrials.gov Identifier: NCT00004650 - Completed
Osteoporosis
- Manipulation of the Intratesticular Hormonal Milieu with Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
ClinicalTrials.gov Identifier: NCT00156650 - Completed
Contraception
- Hormonal Birth Control and the Risk of Acquiring HIV
ClinicalTrials.gov Identifier: NCT00006324 - Completed
HIV Infections; HIV Seronegativity
- Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
ClinicalTrials.gov Identifier: NCT00006133 - Completed
Systemic Lupus Erythematosus
- Estrogen and Graft Atherosclerosis Research Trial (EAGER)
ClinicalTrials.gov Identifier: NCT00000605 - Completed
Cardiovascular Diseases; Coronary Arteriosclerosis; Coronary Disease; Heart Diseases; Myocardial Ischemia; Postmenopause
- Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
ClinicalTrials.gov Identifier: NCT00000559 - Completed
Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Ischemia; Postmenopause
- Postmenopausal Estrogen/Progestin Interventions (PEPI)
ClinicalTrials.gov Identifier: NCT00000466 - Completed
Bone Diseases; Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Ischemia; ...
- Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00044837 - Terminated
HIV Infections
- Hormonal Contraception and Risk of Chlamydia and Gonorrhea
ClinicalTrials.gov Identifier: NCT00091728 - Terminated
Chlamydia Infection; Neisseriaceae Infection
email this page
print this page
bookmark this page
feedback on this page
